Iridex IRIX
NASDAQ IRIX
$0.64 +0.01 (+1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Iridex (IRIX) Gains from Sales and Divestitures (2017 - 2022)

Updated

Iridex (IRIX) reported Gains from Sales and Divestitures of $10,000 for Q4 2021.

Analysis

Iridex (IRIX) Gains from Sales and Divestitures (2017 - 2022) Analysis & Trends

For FY2021, Iridex posted Gains from Sales and Divestitures of -$3,000.

  • By year, Gains from Sales and Divestitures came in at -$2,000 in FY2019, -$4,000 in FY2018 and $175,000 in FY2017.
  • The Q4 2021 figure ranks as the highest quarterly Gains from Sales and Divestitures since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Iridex 11.17 Mn -9.71 Mn 4.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 1, 2022 10,000.00
Sep 30, 2017 175,000.00
API Access

Iridex Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=IRIX&period=max&api_key=YOUR_API_KEY